Grey Fox Wealth Advisors’s Pfizer PFE Stock Holding History

Grey Fox Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,122	Closed	-$28.6K	–	467
2025 Q3	$28.6K	Buy	+1,122	New	+$27.7K	0.01%	317
2023 Q2	–	Sell	-4,981	Closed	-$203K	–	399
2023 Q1	$203K	Buy	4,981 +1,377	+38%	+$59.5K	0.12%	94
2022 Q4	$185K	Buy	+3,604	New	+$173K	0.12%	103

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Grey Fox Wealth Advisors's PFE Position: Q4 2025 in Review

Grey Fox Wealth Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 1,122 shares — an estimated $28.6K sold.

Grey Fox Wealth Advisors first reported a position in PFE in Q4 2022 and held it in 3 quarters. The position peaked at $203K in Q1 2023. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Grey Fox Wealth Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Grey Fox Wealth Advisors sold 1,122 Pfizer shares in Q4 2025, an estimated $28.6K.
Grey Fox Wealth Advisors first reported a position in Pfizer in Q4 2022 and held it in 3 quarters.
Grey Fox Wealth Advisors's Pfizer position peaked at $203K in Q1 2023.
2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Grey Fox Wealth Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.